It is downregulated in liver, stomach, and kidney carcinomas and upregulated in thyroid, esophageal, colon, pancreatic, and lung carcinomas.204 In liver cancer, upregulating the crotonylation level by knocking down HDACs or adding HDAC inhibitors could inhibit hepatoma cell motility and proliferation. Here, HDAC9 is linked to liver cancer.